Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Denmark.
Radiother Oncol. 2022 Jul;172:126-133. doi: 10.1016/j.radonc.2022.05.002. Epub 2022 May 8.
In a recent study, setup uncertainties in the direction of the heart were shown to impact the overall survival of non-small cell lung cancer (NSCLC) patients after radiotherapy, indicating the causal effect between heart irradiation and survival. The current study aims to externally evaluate this observation within a patient cohort treated using daily IGRT.
NSCLC patients with locally-advanced disease and daily CBCT were included. For all treatment fractions, the distance between the isocenter and the heart was evaluated based on the clinical setup registrations. The variation in heart position between planning and treatment (DeltaDistance) was estimated from these registrations. The possible impact of DeltaDistance on survival was analysed by a multivariable Cox model of overall survival, allowing for a time-dependent impact of DeltaDistance to allow for toxicity latency.
Daily CBCT information was available for 489 patients at Odense University Hospital. The primary Cox model contained GTV volume, patient age, performance status, and DeltaDistance. DeltaDistance significantly impacted overall survival approximately 50 months after radiotherapy. Subanalyses indicated that the observed effect is mainly present among the patients with the least clinical risk factors.
Our results confirm the impact of setup variations in the direction of the heart on the survival of NSCLC patients, even within a cohort using daily CBCT setup guidance. This result indicates a causal effect between heart irradiation and survival. It will be challenging to reduce the setup uncertainty even further; thus, increased focus on dose constraints on the heart seems warranted.
在最近的一项研究中,研究人员表明,心脏方向的摆位不确定性会影响接受放疗的非小细胞肺癌(NSCLC)患者的总生存率,这表明心脏照射与生存之间存在因果关系。本研究旨在通过使用每日图像引导放疗(IGRT)治疗的患者队列来外部评估这一观察结果。
本研究纳入了局部晚期疾病和每日 CBCT 的 NSCLC 患者。对于所有治疗分次,根据临床摆位记录评估等中心与心脏之间的距离。从这些注册中估计心脏位置在计划和治疗之间的变化(DeltaDistance)。通过多变量 Cox 模型分析 DeltaDistance 对总生存率的可能影响,允许 DeltaDistance 对生存产生时间依赖性影响,以允许毒性潜伏期。
在奥胡斯大学医院,共有 489 名患者可获得每日 CBCT 信息。主要的 Cox 模型包含 GTV 体积、患者年龄、表现状态和 DeltaDistance。DeltaDistance 在放疗后约 50 个月显著影响总生存率。亚分析表明,观察到的效应主要存在于临床风险因素最少的患者中。
我们的结果证实了心脏方向的摆位变化对 NSCLC 患者生存的影响,即使在使用每日 CBCT 摆位指导的队列中也是如此。这一结果表明心脏照射与生存之间存在因果关系。即使进一步降低摆位不确定性也将具有挑战性;因此,似乎有必要更加关注心脏的剂量限制。